IN8bio shares surge on positive results from leukemia treatment trial

IN8bio

12/12/2023 12:12

** Shares of drug developer IN8bio Inc  INAB.O  surge 20.31%
premarket to $1.54 
    ** Co announces positive clinical update in phase one trial
of its leukemia treatment, INB-100
    ** LSEG data says INAB set to open at its highest since late
July, should gains hold
    ** According to new data, INB-100 showed "Durable complete
remission (CR) achieved in 100% of treated patients," including
high risk patients
    ** INAB shares down 44.58% YTD 

 (Kanchana Chakravarty in Bengaluru)
 ((Kanchana.Chakravarty@thomsonreuters.com))